NLS Pharmaceutics Ltd

NASDAQ:NLSP   3:59:42 PM EDT
3.24
-0.04 (-1.22%)
Products

NLS Pharmaceutics Obtains License To Full Regulatory Data For Sanorex

Published: 03/12/2021 13:15 GMT
NLS Pharmaceutics Ltd (NLSP) - Nls Pharmaceutics Obtains License to Full Regulatory Data Package and Proprietary Know-how for Sanorex® (mazindol).
Nls Pharmaceutics Ag - Agreement Provides Exclusive Rights to All Available Data Included in Original New Drug Application for Mazindol in U.S.nls Pharmaceutics - Deal Includes Right to Sublicense Or Assign License to Third Parties, Subject to Such Third Parties Meeting Certain Obligations.